← Leaderboards
Bogdan A Czerniak
University Of Texas Md Anderson Can Ctr
$13,889,235
Attributed
$16,084,888
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,193,622 · 16
By mechanism
U01$6,093,088 · 1
P50$3,460,924 · 8
R01$2,910,479 · 2
P01$2,663,384 · 3
T32$1,688,145 · 1
U54$1,377,602 · 1
Top collaborators
- H. Barton Grossman5 shared
- Khandan Keyomarsi5 shared
- Randall E Millikan5 shared
- Aysegul Sahin5 shared
- David J Mcconkey1 shared
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Jean-Pierre J Issa$21,637,643
- Jill M Schumacher$2,351,688
- William Francis Benedict$3,785,293
- Margaret R Spitz$17,223,484
- John L Clifford$553,681
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingEarly DiagnosisMalignant Neoplasm Of Urinary BladderBladderPathologyBladder NeoplasmMalignant NeoplasmsHistologicGrantMapsTumorTissuesClinical ResearchDetectionCarcinogenesisOrganBaseGeneticResearch PersonnelUrineDiagnosisBiomarkerResourcesInstitution
Grant awards (51)
Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy.$2,108,734
P01 · FY2025 · CA · contact PI
Project 1: Understanding the Evolution of Bladder Cancer from Field Effects$360,274
P01 · FY2025 · CA · contact PI
Administrative Core$194,376
P01 · FY2025 · CA · contact PI
Tissue and Pathology Resources$272,690
U54 · FY2016 · CA · contact PI
Improving Diagnosis of Bladder Cancer$220,071
P50 · FY2016 · CA · contact PI
Pathology and Data Management$214,647
P50 · FY2016 · CA · contact PI
Multidisciplinary Subspecialty Pathology Research Fellowship Program$379,750
T32 · FY2015 · CA
Tissue and Pathology Resources$266,116
U54 · FY2015 · CA · contact PI
Improving Diagnosis of Bladder Cancer$221,331
P50 · FY2015 · CA · contact PI
Pathology and Data Management$215,854
P50 · FY2015 · CA · contact PI
Multidisciplinary Subspecialty Pathology Research Fellowship Program$282,498
T32 · FY2014 · CA
Tissue and Pathology Resources$276,533
U54 · FY2014 · CA · contact PI
Improving Diagnosis of Bladder Cancer$218,720
P50 · FY2014 · CA · contact PI
Pathology and Data Management$213,576
P50 · FY2014 · CA · contact PI
Multidisciplinary Subspecialty Pathology Research Fellowship Program$373,261
T32 · FY2013 · CA
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer$363,534
R01 · FY2013 · CA · contact PI
Tissue and Pathology Resources$274,404
U54 · FY2013 · CA · contact PI
Improving Diagnosis of Bladder Cancer$217,418
P50 · FY2013 · CA · contact PI
Pathology and Data Management$212,430
P50 · FY2013 · CA · contact PI
Multidisciplinary Subspecialty Pathology Research Fellowship Program$438,857
T32 · FY2012 · CA
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer$390,765
R01 · FY2012 · CA · contact PI
Tissue and Pathology Resources$287,859
U54 · FY2012 · CA · contact PI
Improving Diagnosis of Bladder Cancer$203,201
P50 · FY2012 · CA · contact PI
Pathology and Data Management$203,199
P50 · FY2012 · CA · contact PI
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer$395,127
R01 · FY2011 · CA · contact PI
Multidisciplinary Subspecialty Pathology Research Fellowship Program$213,779
T32 · FY2011 · CA
Aurora Kinase A as a Biomarker for the Detection of Bladder Cancer$432,327
R01 · FY2010 · CA · contact PI
Forerunner Genes: A Novel Class of Early Detection Markers for Bladder Cancer$313,275
P50 · FY2010 · CA · contact PI
Specimen Core$158,670
P50 · FY2010 · CA · contact PI
EARLY DETECTION OF URINARY BLADDER CANCER$394,690
U01 · FY2009 · CA · contact PI
Forerunner Genes: A Novel Class of Early Detection Markers for Bladder Cancer$317,340
P50 · FY2009 · CA · contact PI
Specimen Core$161,194
P50 · FY2009 · CA · contact PI
EARLY DETECTION OF URINARY BLADDER CANCER$527,583
U01 · FY2008 · CA · contact PI
Forerunner Genes: A Novel Class of Early Detection Markers for Bladder Cancer$245,125
P50 · FY2008 · CA · contact PI
Specimen Core$124,873
P50 · FY2008 · CA · contact PI
EARLY DETECTION OF URINARY BLADDER CANCER$513,620
U01 · FY2007 · CA · contact PI
EARLY DETECTION OF URINARY BLADDER CANCER$515,000
U01 · FY2006 · CA · contact PI
Paradigm of Multistep Urinary Bladder Carcinogenesis$260,726
R01 · FY2006 · CA · contact PI
EARLY DETECTION OF URINARY BLADDER CANCER$540,874
U01 · FY2005 · CA
Paradigm of Multistep Urinary Bladder Carcinogenesis$267,000
R01 · FY2005 · CA
EARLY DETECTION OF URINARY BLADDER CANCER$471,643
U01 · FY2004 · CA
Paradigm of Multistep Urinary Bladder Carcinogenesis$267,000
R01 · FY2004 · CA
EARLY DETECTION OF URINARY BLADDER CANCER$774,078
U01 · FY2003 · CA
Paradigm of Multistep Urinary Bladder Carcinogenesis$267,000
R01 · FY2003 · CA
EARLY DETECTION OF URINARY BLADDER CANCER$773,988
U01 · FY2002 · CA
Paradigm of Multistep Urinary Bladder Carcinogenesis$267,000
R01 · FY2002 · CA
EARLY DETECTION AND CHEMOPREVENTION OF BLADDER CANCER$0
P50 · FY2002 · CA
CORE--TISSUE RESOURCE AND PATHOLOGY$0
P50 · FY2002 · CA
EARLY DETECTION OF URINARY BLADDER CANCER$846,674
U01 · FY2001 · CA
EARLY DETECTION AND CHEMOPREVENTION OF BLADDER CANCER$0
P50 · FY2001 · CA
EARLY DETECTION OF URINARY BLADDER CANCER$734,938
U01 · FY2000 · CA